Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Nov 15;102(10):1866–1873. doi: 10.1172/JCI3692

Histamine inhibits the production of interleukin-12 through interaction with H2 receptors.

T C van der Pouw Kraan 1, A Snijders 1, L C Boeije 1, E R de Groot 1, A E Alewijnse 1, R Leurs 1, L A Aarden 1
PMCID: PMC509137  PMID: 9819373

Abstract

IL-12 is essential for T helper 1 (Th1) development and inhibits the induction of Th2 responses. Atopic diseases, which are characterized by Th2 responses, are associated with the overproduction of histamine. Here we present evidence that histamine, at physiological concentrations, strongly inhibits human IL-12 p40 and p70 mRNA and protein production by human monocytes. The use of specific histamine receptor antagonists reveals that this inhibition is mediated via the H2 receptor and induction of intracellular cAMP. The inhibition of IL-12 production is independent of IL-10 and IFN-gamma. The observation that histamine strongly reduces the production of the Th1-inducing cytokine IL-12 implies a positive feedback mechanism for the development of Th2 responses in atopic patients.

Full Text

The Full Text of this article is available as a PDF (270.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., De Groot E. R., Schaap O. L., Lansdorp P. M. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987 Oct;17(10):1411–1416. doi: 10.1002/eji.1830171004. [DOI] [PubMed] [Google Scholar]
  2. Beer D. J., Matloff S. M., Rocklin R. E. The influence of histamine on immune and inflammatory responses. Adv Immunol. 1984;35:209–268. doi: 10.1016/s0065-2776(08)60577-5. [DOI] [PubMed] [Google Scholar]
  3. Bodor J., Spetz A. L., Strominger J. L., Habener J. F. cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3536–3541. doi: 10.1073/pnas.93.8.3536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bouaboula M., Legoux P., Pességué B., Delpech B., Dumont X., Piechaczyk M., Casellas P., Shire D. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem. 1992 Oct 25;267(30):21830–21838. [PubMed] [Google Scholar]
  5. Brockmeyer N. H., Kreuzfelder E., Mertins L., Chalabi N., Kirch W., Scheiermann N., Goos M., Ohnhaus E. E. Immunomodulatory properties of cimetidine in ARC patients. Clin Immunol Immunopathol. 1988 Jul;48(1):50–60. doi: 10.1016/0090-1229(88)90156-0. [DOI] [PubMed] [Google Scholar]
  6. Cameron W., Doyle K., Rocklin R. E. Histamine type I (H1) receptor radioligand binding studies on normal T cell subsets, B cells, and monocytes. J Immunol. 1986 Mar 15;136(6):2116–2120. [PubMed] [Google Scholar]
  7. Casolaro V., Spadaro G., Marone G. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis. 1990 Nov;142(5):1108–1111. doi: 10.1164/ajrccm/142.5.1108. [DOI] [PubMed] [Google Scholar]
  8. Chehimi J., Starr S. E., Frank I., D'Andrea A., Ma X., MacGregor R. R., Sennelier J., Trinchieri G. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med. 1994 Apr 1;179(4):1361–1366. doi: 10.1084/jem.179.4.1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Clerici M., Hakim F. T., Venzon D. J., Blatt S., Hendrix C. W., Wynn T. A., Shearer G. M. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest. 1993 Mar;91(3):759–765. doi: 10.1172/JCI116294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Coffey R. G., Alberts V. A., Weakland L. L. Prostaglandin-dependent desensitization of human monocyte cAMP responses. J Leukoc Biol. 1990 Dec;48(6):557–564. doi: 10.1002/jlb.48.6.557. [DOI] [PubMed] [Google Scholar]
  11. D'Andrea A., Aste-Amezaga M., Valiante N. M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 1993 Sep 1;178(3):1041–1048. doi: 10.1084/jem.178.3.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. D'Andrea A., Ma X., Aste-Amezaga M., Paganin C., Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med. 1995 Feb 1;181(2):537–546. doi: 10.1084/jem.181.2.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. D'Andrea A., Rengaraju M., Valiante N. M., Chehimi J., Kubin M., Aste M., Chan S. H., Kobayashi M., Young D., Nickbarg E. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med. 1992 Nov 1;176(5):1387–1398. doi: 10.1084/jem.176.5.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Delemarre F. G., Stevenhagen A., Kroon F. P., van Eer M. Y., Meenhorst P. L., van Furth R. Reduced toxoplasmastatic activity of monocytes and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2. AIDS. 1995 May;9(5):441–445. [PubMed] [Google Scholar]
  15. Dohlsten M., Kalland T., Sjögren H. O., Carlsson R. Histamine inhibits interleukin 1 production by lipopolysaccharide-stimulated human peripheral blood monocytes. Scand J Immunol. 1988 May;27(5):527–532. doi: 10.1111/j.1365-3083.1988.tb02379.x. [DOI] [PubMed] [Google Scholar]
  16. Dohlsten M., Sjögren H. O., Carlsson R. Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-gamma production. Cell Immunol. 1987 Oct 1;109(1):65–74. doi: 10.1016/0008-8749(87)90292-9. [DOI] [PubMed] [Google Scholar]
  17. Dyer J., Warren K., Merlin S., Metcalfe D. D., Kaliner M. Measurement of plasma histamine: description of an improved method and normal values. J Allergy Clin Immunol. 1982 Aug;70(2):82–87. doi: 10.1016/0091-6749(82)90233-0. [DOI] [PubMed] [Google Scholar]
  18. Foley P., Kazazi F., Biti R., Sorrell T. C., Cunningham A. L. HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology. 1992 Mar;75(3):391–397. [PMC free article] [PubMed] [Google Scholar]
  19. Gaddy J. N., Busse W. W. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma. Am Rev Respir Dis. 1986 Nov;134(5):969–974. doi: 10.1164/arrd.1986.134.5.969. [DOI] [PubMed] [Google Scholar]
  20. Gately M. K., Desai B. B., Wolitzky A. G., Quinn P. M., Dwyer C. M., Podlaski F. J., Familletti P. C., Sinigaglia F., Chizonnite R., Gubler U. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol. 1991 Aug 1;147(3):874–882. [PubMed] [Google Scholar]
  21. Haraguchi S., Good R. A., Day N. K. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol Today. 1995 Dec;16(12):595–603. doi: 10.1016/0167-5699(95)80083-2. [DOI] [PubMed] [Google Scholar]
  22. Hayes M. P., Wang J., Norcross M. A. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood. 1995 Jul 15;86(2):646–650. [PubMed] [Google Scholar]
  23. Helle M., Boeije L., de Groot E., de Vos A., Aarden L. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods. 1991 Apr 8;138(1):47–56. doi: 10.1016/0022-1759(91)90063-l. [DOI] [PubMed] [Google Scholar]
  24. Hill S. J. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev. 1990 Mar;42(1):45–83. [PubMed] [Google Scholar]
  25. Hofmann B., Nishanian P., Nguyen T., Liu M., Fahey J. L. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS. 1993 May;7(5):659–664. doi: 10.1097/00002030-199305000-00008. [DOI] [PubMed] [Google Scholar]
  26. Hsieh C. S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993 Apr 23;260(5107):547–549. doi: 10.1126/science.8097338. [DOI] [PubMed] [Google Scholar]
  27. Jakob T., Huspith B. N., Latchman Y. E., Rycroft R., Brostoff J. Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis. Clin Exp Immunol. 1990 Mar;79(3):380–384. doi: 10.1111/j.1365-2249.1990.tb08099.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kapsenberg M. L., Jansen H. M., Bos J. D., Wierenga E. A. Role of type 1 and type 2 T helper cells in allergic diseases. Curr Opin Immunol. 1992 Dec;4(6):788–793. doi: 10.1016/0952-7915(92)90063-k. [DOI] [PubMed] [Google Scholar]
  29. Karp C. L., Wysocka M., Wahl L. M., Ahearn J. M., Cuomo P. J., Sherry B., Trinchieri G., Griffin D. E. Mechanism of suppression of cell-mediated immunity by measles virus. Science. 1996 Jul 12;273(5272):228–231. doi: 10.1126/science.273.5272.228. [DOI] [PubMed] [Google Scholar]
  30. Kimata H., Fujimoto M., Ishioka C., Yoshida A. Histamine selectively enhances human immunoglobulin E (IgE) and IgG4 production induced by anti-CD58 monoclonal antibody. J Exp Med. 1996 Aug 1;184(2):357–364. doi: 10.1084/jem.184.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kunkel S. L., Spengler M., May M. A., Spengler R., Larrick J., Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem. 1988 Apr 15;263(11):5380–5384. [PubMed] [Google Scholar]
  32. Leung D. Y., Key L., Steinberg J. J., Young M. C., Von Deck M., Wilkinson R., Geha R. S. Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome. J Immunol. 1988 Jan 1;140(1):84–88. [PubMed] [Google Scholar]
  33. Leurs R., Smit M. J., Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmacol Ther. 1995 Jun;66(3):413–463. doi: 10.1016/0163-7258(95)00006-3. [DOI] [PubMed] [Google Scholar]
  34. Ma X., Chow J. M., Gri G., Carra G., Gerosa F., Wolf S. F., Dzialo R., Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med. 1996 Jan 1;183(1):147–157. doi: 10.1084/jem.183.1.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ma X., D'Andrea A., Kubin M., Aste-Amezaga M., Sartori A., Monteiro J., Showe L., Wysocka M., Trinchieri G. Production of interleukin-12. Res Immunol. 1995 Sep-Oct;146(7-8):432–438. doi: 10.1016/0923-2494(96)83012-4. [DOI] [PubMed] [Google Scholar]
  36. Marone G., Giugliano R., Lembo G., Ayala F. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. J Invest Dermatol. 1986 Jul;87(1):19–23. doi: 10.1111/1523-1747.ep12523520. [DOI] [PubMed] [Google Scholar]
  37. Marshall J. D., Robertson S. E., Trinchieri G., Chehimi J. Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients. J Immunol. 1997 Dec 1;159(11):5705–5714. [PubMed] [Google Scholar]
  38. Marth T., Kelsall B. L. Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med. 1997 Jun 2;185(11):1987–1995. doi: 10.1084/jem.185.11.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Mastino A., Grelli S., Piacentini M., Oliverio S., Favalli C., Perno C. F., Garci E. Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell Immunol. 1993 Nov;152(1):120–130. doi: 10.1006/cimm.1993.1272. [DOI] [PubMed] [Google Scholar]
  40. Meyaard L., Hovenkamp E., Pakker N., van der Pouw Kraan T. C., Miedema F. Interleukin-12 (IL-12) production in whole blood cultures from human immunodeficiency virus-infected individuals studied in relation to IL-10 and prostaglandin E2 production. Blood. 1997 Jan 15;89(2):570–576. [PubMed] [Google Scholar]
  41. Meyaard L., Otto S. A., Keet I. P., van Lier R. A., Miedema F. Changes in cytokine secretion patterns of CD4+ T-cell clones in human immunodeficiency virus infection. Blood. 1994 Dec 15;84(12):4262–4268. [PubMed] [Google Scholar]
  42. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi: 10.1146/annurev.iy.07.040189.001045. [DOI] [PubMed] [Google Scholar]
  43. Murphy T. L., Cleveland M. G., Kulesza P., Magram J., Murphy K. M. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol Cell Biol. 1995 Oct;15(10):5258–5267. doi: 10.1128/mcb.15.10.5258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Naclerio R. M., Proud D., Togias A. G., Adkinson N. F., Jr, Meyers D. A., Kagey-Sobotka A., Plaut M., Norman P. S., Lichtenstein L. M. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11;313(2):65–70. doi: 10.1056/NEJM198507113130201. [DOI] [PubMed] [Google Scholar]
  45. O'Garra A., Murphy K. T-cell subsets in autoimmunity. Curr Opin Immunol. 1993 Dec;5(6):880–886. doi: 10.1016/0952-7915(93)90100-7. [DOI] [PubMed] [Google Scholar]
  46. Panina-Bordignon P., Mazzeo D., Lucia P. D., D'Ambrosio D., Lang R., Fabbri L., Self C., Sinigaglia F. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest. 1997 Sep 15;100(6):1513–1519. doi: 10.1172/JCI119674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Ptak W., Geba G. P., Askenase P. W. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine. J Immunol. 1991 Jun 1;146(11):3929–3936. [PubMed] [Google Scholar]
  48. Punnonen J., Aversa G., Cocks B. G., McKenzie A. N., Menon S., Zurawski G., de Waal Malefyt R., de Vries J. E. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3730–3734. doi: 10.1073/pnas.90.8.3730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Raible D. G., Schulman E. S., DiMuzio J., Cardillo R., Post T. J. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. J Immunol. 1992 Jun 1;148(11):3536–3542. [PubMed] [Google Scholar]
  50. Scharton-Kersten T., Afonso L. C., Wysocka M., Trinchieri G., Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol. 1995 May 15;154(10):5320–5330. [PubMed] [Google Scholar]
  51. Schindler R., Dinarello C. A. A method for removing interleukin-1- and tumor necrosis factor-inducing substances from bacterial cultures by ultrafiltration with polysulfone. J Immunol Methods. 1989 Jan 17;116(2):159–165. doi: 10.1016/0022-1759(89)90199-3. [DOI] [PubMed] [Google Scholar]
  52. Smit M. J., Leurs R., Shukrula S. R., Bast A., Timmerman H. Rapid desensitization of the histamine H2 receptor on the human monocytic cell line U937. Eur J Pharmacol. 1994 Dec 15;288(1):17–25. doi: 10.1016/0922-4106(94)90005-1. [DOI] [PubMed] [Google Scholar]
  53. Snijders A., Hilkens C. M., van der Pouw Kraan T. C., Engel M., Aarden L. A., Kapsenberg M. L. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J Immunol. 1996 Feb 1;156(3):1207–1212. [PubMed] [Google Scholar]
  54. Snijdewint F. G., Kaliński P., Wierenga E. A., Bos J. D., Kapsenberg M. L. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol. 1993 Jun 15;150(12):5321–5329. [PubMed] [Google Scholar]
  55. Strassmann G., Patil-Koota V., Finkelman F., Fong M., Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med. 1994 Dec 1;180(6):2365–2370. doi: 10.1084/jem.180.6.2365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Tasaka K., Kurokawa K., Nakayama Y., Kakimoto M. Effect of histamine on delayed-type hypersensitivity in mice. Immunopharmacology. 1986 Aug;12(1):69–77. doi: 10.1016/0162-3109(86)90053-6. [DOI] [PubMed] [Google Scholar]
  57. Testa B., Mazzei F., Mesolella M., Maione A., Testa D., Mesolella C. Histamine 2 antagonists in allergic rhinitis. Relationship of clinical response and serum concentrations of total and specific IgE antibody levels. Arch Otolaryngol Head Neck Surg. 1989 Aug;115(8):950–953. doi: 10.1001/archotol.1989.01860320060019. [DOI] [PubMed] [Google Scholar]
  58. Trask D. M., Chan S. C., Sherman S. E., Hanifin J. M. Altered leukocyte protein kinase activity in atopic dermatitis. J Invest Dermatol. 1988 Apr;90(4):526–531. doi: 10.1111/1523-1747.ep12461047. [DOI] [PubMed] [Google Scholar]
  59. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 1994 Dec 15;84(12):4008–4027. [PubMed] [Google Scholar]
  60. Van der Pouw-Kraan T., Van Kooten C., Rensink I., Aarden L. Interleukin (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production. Eur J Immunol. 1992 May;22(5):1237–1241. doi: 10.1002/eji.1830220519. [DOI] [PubMed] [Google Scholar]
  61. Vannier E., Miller L. C., Dinarello C. A. Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors. J Exp Med. 1991 Jul 1;174(1):281–284. doi: 10.1084/jem.174.1.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Wierenga E. A., Snoek M., de Groot C., Chrétien I., Bos J. D., Jansen H. M., Kapsenberg M. L. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol. 1990 Jun 15;144(12):4651–4656. [PubMed] [Google Scholar]
  63. Wolf S. F., Temple P. A., Kobayashi M., Young D., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., Hewick R. M. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol. 1991 May 1;146(9):3074–3081. [PubMed] [Google Scholar]
  64. Yang P. C., Liu T., Zhang T. Y., Fan D. S. The effect of the H2 antagonist cimetidine on the numbers of CD4+ and CD8+ cells in the nasal mucosa of patients with allergic rhinitis. Clin Otolaryngol Allied Sci. 1997 Apr;22(2):93–95. doi: 10.1046/j.1365-2273.1997.d01-294.x. [DOI] [PubMed] [Google Scholar]
  65. van der Pouw Kraan T. C., Boeije L. C., Smeenk R. J., Wijdenes J., Aarden L. A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med. 1995 Feb 1;181(2):775–779. doi: 10.1084/jem.181.2.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. van der Pouw Kraan T. C., Boeije L. C., Snijders A., Smeenk R. J., Wijdenes J., Aarden L. A. Regulation of IL-12 production by human monocytes and the influence of prostaglandin E2. Ann N Y Acad Sci. 1996 Oct 31;795:147–157. doi: 10.1111/j.1749-6632.1996.tb52663.x. [DOI] [PubMed] [Google Scholar]
  67. van der Pouw Kraan T. C., Boeije L. C., de Groot E. R., Stapel S. O., Snijders A., Kapsenberg M. L., van der Zee J. S., Aarden L. A. Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J Immunol. 1997 Jun 1;158(11):5560–5565. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES